In 1,208 adults with cirrhosis or high-risk hepatitis B, adding AFP, AFP-L3 and DCP to biannual ultrasound did not improve early-stage hepatocellular carcinoma detection vs ultrasound alone (HR 0.81, P=.45).
RCTn = 1,208
Hirode et al. Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial